全文获取类型
收费全文 | 73715篇 |
免费 | 5247篇 |
国内免费 | 149篇 |
专业分类
耳鼻咽喉 | 501篇 |
儿科学 | 2861篇 |
妇产科学 | 2582篇 |
基础医学 | 8682篇 |
口腔科学 | 901篇 |
临床医学 | 12638篇 |
内科学 | 13517篇 |
皮肤病学 | 1173篇 |
神经病学 | 6753篇 |
特种医学 | 1242篇 |
外国民族医学 | 33篇 |
外科学 | 6304篇 |
综合类 | 939篇 |
一般理论 | 106篇 |
预防医学 | 10526篇 |
眼科学 | 895篇 |
药学 | 4299篇 |
1篇 | |
中国医学 | 123篇 |
肿瘤学 | 5035篇 |
出版年
2023年 | 447篇 |
2022年 | 551篇 |
2021年 | 1366篇 |
2020年 | 984篇 |
2019年 | 1603篇 |
2018年 | 1828篇 |
2017年 | 1329篇 |
2016年 | 1474篇 |
2015年 | 1624篇 |
2014年 | 2239篇 |
2013年 | 3668篇 |
2012年 | 5250篇 |
2011年 | 5474篇 |
2010年 | 2960篇 |
2009年 | 2792篇 |
2008年 | 4788篇 |
2007年 | 5378篇 |
2006年 | 5132篇 |
2005年 | 5084篇 |
2004年 | 4869篇 |
2003年 | 4580篇 |
2002年 | 4343篇 |
2001年 | 597篇 |
2000年 | 432篇 |
1999年 | 582篇 |
1998年 | 917篇 |
1997年 | 718篇 |
1996年 | 627篇 |
1995年 | 554篇 |
1994年 | 531篇 |
1993年 | 505篇 |
1992年 | 359篇 |
1991年 | 315篇 |
1990年 | 318篇 |
1989年 | 267篇 |
1988年 | 244篇 |
1987年 | 252篇 |
1986年 | 229篇 |
1985年 | 267篇 |
1984年 | 296篇 |
1983年 | 280篇 |
1982年 | 355篇 |
1981年 | 318篇 |
1980年 | 263篇 |
1979年 | 183篇 |
1978年 | 164篇 |
1977年 | 171篇 |
1976年 | 132篇 |
1975年 | 128篇 |
1973年 | 110篇 |
排序方式: 共有10000条查询结果,搜索用时 86 毫秒
951.
952.
953.
954.
Change of appetite in patients with functional digestive disorder. Association with psychological disorders: A cross‐sectional study 下载免费PDF全文
Marinos Fysekidis Michel Bouchoucha Florence Mary Gheorghe Airinei Cyriaque Bon Robert Benamouzig 《Journal of gastroenterology and hepatology》2018,33(1):195-202
Background and Aims
Changes in appetite are a frequent complaint in patients with functional gastrointestinal disorders (FGIDs). The aims of this study are to evaluate whether the changes in appetite are associated with specific FGIDs and to explore associations of these changes with symptoms of anxiety or depression.Methods
This study included 1009 consecutive FGID patients (71% female), aged 48.9 years who all filled out a Rome III questionnaire for the evaluation of FGIDs, submitted to a psychological evaluation of symptoms of anxiety, and completed the Beck Depression Inventory questionnaire. The patients were classified according to their appetite change using a 7‐point grading scale and split into three groups: those with appetite loss, those with no change in appetite, and those with increased appetite.Results
Among the 1009, 496 patients (49%) reported a change in appetite, of which 332 (33%) patients reported a decrease in appetite and 164 (16%) patients reported an increase in appetite. Appetite was not affected in 51% of patients. Changes in appetite depended on gender, body mass index and psychometric evaluation scores. Increased appetite did not have specific FGIDs associations, while decreased appetite was associated with esophageal, gastroduodenal, bowel, and anorectal symptoms. The presence of depressive symptoms was also a predictor for the majority of FGIDs in decreased appetite, while anxiety trait was significant for globus and dysphagia.Conclusions
Decreased appetite was associated with FGIDs, especially in the presence of depressive symptoms. A reduced appetite would help to predict psychological disorders associated with FGIDs.Financial disclosure
None declared.Legal registration
This study was a registered study in the French National Drug Agency (ANSM, Agence Nationale de Securité du Medicamentet des produits de santé, Study Number 2016‐A01120‐51).Competing interests
Michel Bouchoucha, Marinos Fysekidis, Florence Mary, Gheorghe Airinei, Cyriaque Bon, and Robert Benamouzig have no competitive interests. 相似文献955.
956.
957.
958.
959.
K. Alexandra Acosta Mary Claire Haver Brent Kelly 《American journal of clinical dermatology》2013,14(3):215-222
Erythema nodosum (EN) is the most common form of panniculitis. It is characterized by erythematous, raised, tender nodules that usually occur bilaterally on the extensor surfaces of the lower extremities. EN is associated with many underlying conditions including infection, sarcoidosis, malignancy, and pregnancy. Its underlying etiology, however, is unknown in up to half of cases. Pregnancy is thought to create an optimal background for EN to develop, although the exact mechanisms are unclear. Immune complexes may play a role in the pathogenesis of EN during pregnancy, or EN may be a hypersensitivity reaction to either estrogens or progesterone. EN is a self-limiting process, and non-pharmacologic means such as bed rest and elastic web bandages may be sufficient to control the symptoms. Potassium iodide, systemic and intralesional corticosteroids, non-steroidal anti-inflammatory drugs, salicylates, tumor necrosis factor-α inhibitors, hydroxychloroquine, colchicine, and dapsone are other treatment options available, but some of these drugs are contraindicated in pregnancy while others are considered safe. Before prescribing one of these treatments to a pregnant patient, the patient’s obstetrician should be consulted, and a careful risk-benefit analysis should be performed. 相似文献
960.
'If anticoagulants had been administered sooner, my client would not have died' was a central claim put to us, as statistician expert witnesses, by a Claimant's and Defendant's lawyers. To assist other litigants, and without identifying the specific case, we set out the study types that contribute to the evidence base, and their limitations. We then explain why it is difficult to adduce evidence about the relative risk of dying from pulmonary embolism within 12 hours of admission to accident and emergency even when it is well accepted that anticoagulation reduces the risk of dying within the next seven days of patients at objectively confirmed risk of pulmonary embolism. No matter how much we may want an answer, or how tragic an individual outcome, we can only work from the available evidence or work to improve the evidence base, which needs to be resourced. 相似文献